Advertisement

Organisation › Details
Sanofi S.A. (Euronext: SAN, Nasdaq: SNY)
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *
![]() |
Start | 2011-05-06 renamed |
Group | Sanofi (Group) [since May 2011] | |
Predecessor | Sanofi-Aventis S.A. (EURONEXT: SAN, NYSE: SNY) | |
![]() |
Industry | pharmaceutical |
![]() |
Person | Hudson, Paul (Sanofi 201909– CEO before Novartis Head Pharma before AstraZeneca + Schering-Plough) |
Person 2 | Contamine, Jérôme (Sanofi 2009–201809 CFO RETIRED 9/18) | |
![]() |
Region | Paris |
Country | France | |
Street | 174 avenue de France | |
City | 75635 Paris Cedex 13 | |
Tel | +33-1-5377-4000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | I: 50,001 to 100,0 (2021-12-31) |
Currency | EUR | |
Annual sales | 37,761,000,000 (sales, net, consolidated (2021) 2021-12-31) | |
Profit | 6,279,000,000 (2021-12-31) | |
Cash | 10,098,000,000 (2021-12-31) | |
* Document for �About Section�: | ||
Record changed: 2022-04-04 |
Advertisement
![Picture [iito] No Tracking 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-tracking.jpg)
More documents for Sanofi (Group) [since May 2011]
- [1] Sanofi S.A.. (3/29/22). "Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets". Paris....
- [2] Sanofi S.A.. (3/16/22). "Press Release: Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates". Paris....
- [3] Sanofi S.A.. (3/15/22). "Press Release: Sanofi Announces €300 Million Collaboration with Blackstone Life Sciences to Advance an Innovative Treatment for Multiple Myeloma". Paris....
- [4] Sanofi S.A.. (2/8/22). "Press Release: Sanofi Completes Acquisition of Amunix". Paris....
- [5] Exscientia plc. (1/7/22). "Press Release: Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines". Paris, Oxford & Boston, MA....
- [6] Sanofi S.A.. (12/21/21). "Press Release: Sanofi to Acquire Amunix Immuno-oncology Pipeline with Next Generation Conditionally Activated Biologics". Paris....
- [7] Corteria Pharmaceuticals S.A.S.. (12/9/21). "Press Release: Corteria Pharmaceuticals Announces Closing of €12M Seed Financing to Advance Portfolio Assets". Paris....
- [8] Sanofi S.A.. (12/1/21). "Press Release: Sanofi to Acquire Origimm Biotechnology in First Move to Treat Acne with Vaccine-based Immunotherapy". Paris & Vienna....
- [9] Novalix S.A.S.. (11/30/21). "Press Release: Novalix Signs Partnership Agreement to Design and Screen Sanofi’s New DNA-Encoded Libraries". Strasbourg....
- [10] Sanofi S.A.. (11/18/21). "Press Release: Sanofi Invests $180 Million Equity in Owkin’s Artificial Intelligence and Federated Learning to Advance Oncology Pipeline". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top